bpc-157 multiple sclerosis clinical trial humans Heal or Harm: Body Protective Compound-157 in the Gray Zone BPC157 and Multiple Sclerosis symptom
Description
It has no approved drug application
Educational Notice: All information is provided solely for scientific and educational reference
$319 Feeling miserable and need a boost of your immune system
Consulting a healthcare provider allows for exploring potential treatments such as physical therapy
So why on earth is the BOP trying to restrict B12 as methylcobalamin
In the same way that BPC-157 is monitored, clinicians will keep tabs on symptoms, functional progress, mobility, and periodic test findings to ensure the treatment remains appropriate and is producing the desired results
